(
132
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Baseline demographics and disease characteristics of patients with eosinophilic esophagitis in part A of the 3-part, randomized, placebo-controlled, phase 3 TREET study
-
Difficult to control asthma in adults
-
Difficult to control asthma in children
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
EAACI & WAO joint symposium: World Allergy Forum, Mast cells – biology and disease
-
Improving patient care with allergen immunotherapy (AIT): Lessons learned from randomised control trials (RCT) and real world evidence (RWE) studies
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Pathogenic Th cell population disease induction model: – From the recruitment of eosinophils to the induction of fibrosis
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
Show more Event Resources (8)Show Less-
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Pioneering a new age – fighting allergic disease on all fronts!
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
Show more Sponsored Symposia (2)Show Less-
-
Biologicals in atopic disease in pregnancy: An EAACI position paper
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
Show more Position Papers (3)Show Less-
Website
Collapse
-
A stepwise approach to the management of a patient with celiac disease and multiple IgE-mediated food allergies
-
Abatacept (cytotoxic T lymphocyte antigen 4-fragment crystallizable) treatment suppressed disease activity in a mouse model of Eosinophilic CRS
-
Acquired angioedema: addressing the underlying disease
-
Allergic Contact Dermatitis in the Era of Glycemic Control Devices: Unveiling Sensitizing Allergens and Boosting Device Tolerance via Immunomodulation
-
Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
-
Basal serum tryptase levels identify hereditary α-tryptasemia but are poor predictors of clonal mast cell disease in Hymenoptera venom allergy
-
Baseline Demographics and Disease Characteristics of Pediatric Patients with Eosinophilic Esophagitis (EoE) from the Randomized, Placebo-Controlled, Phase 3 EoE KIDS Study
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Baseline IgE Levels Predict an Unstable Disease Course in Adults With Severe Atopic Dermatitis That is Stabilized by Dupilumab Therapy
-
Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Benefits of the combination of biologics in the control of a patient with high type 2 profile: a case report
-
Blomia Tropicalis (a house dust mite) is the most important sensitization in patients with Allergic Airways Disease in Reunion Island (Tropical region)
-
Burden of Disease and Health-Related Quality of Life Impairment in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey
-
Can serum biomarkers predict long-term control of allergic rhinitis after immunotherapy?
-
Can we achieve remission or disease modification in CRSwNP?
-
Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis
-
Case report of an occupational disease in a veterinarian with allergic asthma
-
Characteristics and Asthma Control Status of Severe Asthma Patients in the Korean Severe Asthma Registry-2 (KoSAR-2)
-
Clinical experience with targeting TSLP: reducing patient burden of disease
-
Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease
-
Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease
-
Coexistence of Celiac Disease and Wheat Allergy – more than a coincidence?
-
Comorbidity in airways disease and its impact
-
Comparison of the efficacy of omalizumab and mepolizumab in non-steroidal anti-inflammatory drug-exacerbated respiratory disease
-
Dermatomyositis, a dangerous disease hiding in the skin: a case series of atypical presentation
-
Difficult to control hereditary angioedema during pregngancy
-
Disease burden and medication use in children with symptomatic, perennial allergic rhinitis in Canada, Denmark, and the UK: a cross-sectional survey
-
Disease burden in ISM: Using PRO tools to assess the individual patient experience
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Dupilumab Improves Urticaria Activity, Health-Related Quality of Life, and Disease Perception and Severity in Patients with CSU: Results From the LIBERTY-CSU CUPID A Study
-
Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study
-
Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children
-
EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease
-
EAACI & NIAID Joint Symposium : Harnessing the Potential of Endotyping Data to Predict Clinical Outcomes in Allergic Disease
-
Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity
-
Effect of Remibrutinib on Disease Activity in Patients with Chronic Spontaneous Urticaria: Post Hoc Analysis of Phase 3 REMIX-1 and REMIX-2 studies
-
Effects of dupilumab on quality of life and airflow obstruction in refractory type 2 high severe unified airways disease
-
Efficacy of Dupilumab by Baseline Disease Severity in Children Aged 6 to 11 Years With Uncontrolled Moderate-to-Severe Asthma: Post Hoc Results From the Randomized, Placebo-Controlled VOYAGE Trial
-
Endotypes united airways disease
-
Endotyping in Eosinophilic GI disease
-
Evaluation of Disease Activity and Pulmonary Findings in Patients with Primary Immunodeficiency Using Scoring Systems
-
Evaluation of The Development of Respiratory Tract Allergic Disease in Patients With Cow’s Milk Allergy
-
Evaluation of The Development of Respiratory Tract Allergic Disease in Patients With Cow’s Milk Allergy
-
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
-
Exploring cardiovascular disease and mortality in Italian Common Variable Immunodeficiency (CVID) Patients: a multicenter investigation
-
Frequent occurrence of Alzheimer’s disease in patients with IgE-mediated allergies
-
Granulocytic myeloid derived suppressive cells exacerbate disease status in bronchiectasis
-
Hepatic Veno-Occlusive Disease with immunodeficiency Mutation in SP110
-
High burden of disease and risk of comorbidities in children with allergic rhinitis
-
Hymenoptera venom allergy as an occupational disease
-
Immune mechanisms associated with host-microbiome interactions in health and disease
-
Immunodeficiency in a Patient Undergoing Thymectomy for Congenital Heart Disease
-
Immunological Patient Stratification identifies distinct disease mechanisms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
-
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Limiting unnecessary antibiotic use in allergic disease exacerbations
-
Linguistic Adaptation of Urticaria Activity Score Over 7 Days (UAS7) to Latvian: Evaluating Disease Activity in Adult Patients with Chronic Spontaneous Urticaria in Latvia
-
Long-term effects of COVID-19 on the risk of ischemic heart disease in asthma: A nationwide, population-based cohort study
-
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
-
Menarini – From bench to patients-side: improving control of allergic rhinitis symptoms with mometasone furoate/olopatadine
-
Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease
-
Metabolic control of epithelial inflammation
-
Minimal Invasive Endotyping in Nasal Inflammatory Disease
-
Moving Beyond Control to On-Treatment Clinical Remission
-
Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms
-
Peripheral blood and urine lipid mediators are associated with NSAID-exacerbated respiratory disease
-
Pharmacogenetics of adverse effects induced by thiopurine drugs in patients with Inflammatory bowel disease
-
Practical applications of ‘omics’ in chronic airway disease
-
Primary antibody immune deficiencies are often associated with manifestations of allergic disease
-
Primary immunodeficiency in light of Granulomatous Lung Disease
-
Prognostic role of inflammaging markers on major adverse cardiac outcomes in atherosclerotic coronary artery disease
-
Progression of Underlying Disease in Pediatric Severe Asthma
-
RHINA – Biomarkers in inflammatory airway disease
-
RHINA – Disease Mechanisms of CRS: from bench to bedside
-
Rapid clinical and immunological improvement of persistent lymphoproliferative disease in a patient with Activated PI3K Delta Syndrome (APDS)
-
Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years
-
Reimagining Severe Asthma: From Control to Remission
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Sanofi Regeneron – On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control
-
Severe atopic dermatitis: a stand-alone disease or something more?
-
Shifting environmental exposures: a call for evolving allergic disease management
-
Slow crippling lung disease in Ataxia telangiectasia: lung function and CT findings
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
T2 driven disease therapy: How much is too much?
-
The Effectiveness of Educational Interventions on Asthma Management in Children in Primary care settings: Systematic Review of Randomised Control Trials
-
The Eosinophil in Obstructive Airway Disease – Beyond Asthma
-
The Impact of Excess Weight and Obesity on Asthma Control in a Pediatric Population
-
The Prevalence of NSAID‐exacerbated Respiratory Disease in one allergy center from China: Diagnosis adhering to EAACI Position Paper
-
The gut fungome is associated with future risk of exacerbations, asthma control and quality of life in children with uncontrolled asthma: results from the PUFFIN study
-
The immune supportive diet for all patients with allergic disease – is a change is nutritional practice needed?
-
The impact of secretory IgA on nasal microbiome control and its link to the development of chronic rhinosinusitis
-
The parasympathetic nervous system plays a key role in control and stress in patients with asthma
-
The potential role of IgE in Crohn’s disease by impairing the generation of FOXP3+ regulatory T cells by plasmacytoid dendritic cells
-
The potential role of IgE in Crohn’s disease by impairing the generation of FOXP3+ regulatory T cells by plasmacytoid dendritic cells
-
The role of the epithelium as a critical immune-functioning organ in both upper and lower airway disease
-
Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment
-
Unique effect of aspirin on sputum cell composition in patients with NSAID-Exacerbated Respiratory Disease (N-ERD)
-
Unveiling the Connection Between α-Gal Allergy and Cardiovascular Disease
-
Upper respiratory disease and epithelial cytokines as potential therapeutic targets
-
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT
-
What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies
-
Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency
-
Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
Show more Sessions (106)Show Less-